THEOCHRON SRT 300MG DIN 00599905
Health Canada record
| Active ingredient(s) | THEOPHYLLINE 300 MG |
|---|---|
| Dosage form | Tablet (Extended-Release) |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | R03DA04 THEOPHYLLINE |
| Original market date | 31-Dec-1985 |
| Current status date | 20-Jul-2004 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing THEOPHYLLINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00692689 | AA-THEO LA | AA PHARMA INC | Tablet (Extended-Release) | THEOPHYLLINE 100 MG | Marketed |
| 00692700 | AA-THEO LA | AA PHARMA INC | Tablet (Extended-Release) | THEOPHYLLINE 300 MG | Marketed |
| 00692697 | AA-THEO LA | AA PHARMA INC | Tablet (Extended-Release) | THEOPHYLLINE 200 MG | Marketed |
| 02358395 | APO-THEO ER | APOTEX INC | Tablet (Extended-Release) | THEOPHYLLINE 400 MG | Approved |
| 02358409 | APO-THEO ER | APOTEX INC | Tablet (Extended-Release) | THEOPHYLLINE 600 MG | Approved |
| 00627410 | ELIXIR DE THEOPHYLLINE | LABORATOIRE ATLAS INC | Elixir | THEOPHYLLINE 80 MG | Marketed |
| 02360128 | THEO ER | AA PHARMA INC | Tablet (Extended-Release) | THEOPHYLLINE 600 MG | Marketed |
| 02360101 | THEO ER | AA PHARMA INC | Tablet (Extended-Release) | THEOPHYLLINE 400 MG | Marketed |
| 00575151 | PMS-THEOPHYLLINE ELIXIR | PHARMASCIENCE INC | Elixir | THEOPHYLLINE 80 MG | Cancelled Post Market |
| 00466409 | PULMOPHYLLINE ELX | LABORATOIRE RIVA INC. | Elixir | THEOPHYLLINE 80 MG | Dormant |
| 00556742 | QUIBRON T SR TAB 300MG | BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB | Tablet (Extended-Release) | THEOPHYLLINE 300 MG | Cancelled Post Market |
| 01926586 | SLO-BID 100 | AVENTIS PHARMA INC | Capsule (Sustained-Release) | THEOPHYLLINE 100 MG | Cancelled Post Market |
| 01926594 | SLO-BID 200 | AVENTIS PHARMA INC | Capsule (Sustained-Release) | THEOPHYLLINE 200 MG | Cancelled Post Market |
| 01926608 | SLO-BID 300 | AVENTIS PHARMA INC | Capsule (Sustained-Release) | THEOPHYLLINE 300 MG | Cancelled Post Market |
| 01926616 | SLO-BID 50 | AVENTIS PHARMA INC | Capsule (Sustained-Release) | THEOPHYLLINE 50 MG | Cancelled Post Market |
| 00476846 | TEDRAL TAB | PARKE-DAVIS DIVISION, WARNER-LAMBERT CANADA INC. | Tablet | THEOPHYLLINE 118 MG; L-EPHEDRINE HYDROCHLORIDE 24 MG; PHENOBARBITAL 8 MG | Cancelled Post Market |
| 02230087 | TEVA-THEOPHYLLINE SR | TEVA CANADA LIMITED | Tablet (Extended-Release) | THEOPHYLLINE 300 MG | Cancelled Post Market |
| 02230085 | TEVA-THEOPHYLLINE SR | TEVA CANADA LIMITED | Tablet (Extended-Release) | THEOPHYLLINE 100 MG | Cancelled Post Market |
| 02230086 | TEVA-THEOPHYLLINE SR | TEVA CANADA LIMITED | Tablet (Extended-Release) | THEOPHYLLINE 200 MG | Cancelled Post Market |
| 00460982 | THEO-DUR 100 MG | ASTRAZENECA CANADA INC | Tablet (Extended-Release) | THEOPHYLLINE 100 MG | Cancelled Post Market |
| 00460990 | THEO-DUR 200 MG | ASTRAZENECA CANADA INC | Tablet (Extended-Release) | THEOPHYLLINE 200 MG | Cancelled Post Market |
| 00461008 | THEO-DUR 300 MG | ASTRAZENECA CANADA INC | Tablet (Extended-Release) | THEOPHYLLINE 300 MG | Cancelled Post Market |
| 00722065 | THEO-DUR 450 MG | ASTRAZENECA CANADA INC | Tablet (Extended-Release) | THEOPHYLLINE 450 MG | Cancelled Post Market |
| 01926640 | THEO-SR 300 SRT 300MG | RHONE-POULENC RORER CANADA INC. | Tablet (Extended-Release) | THEOPHYLLINE 300 MG | Cancelled Post Market |
| 00631698 | THEOCHRON SRT 100MG | FOREST LABS INC | Tablet (Extended-Release) | THEOPHYLLINE 100 MG | Cancelled Post Market |
| 00631701 | THEOCHRON SRT 200MG | FOREST LABS INC | Tablet (Extended-Release) | THEOPHYLLINE 200 MG | Cancelled Post Market |
| 01966219 | THEOLAIR | BAUSCH HEALTH, CANADA INC. | Solution | THEOPHYLLINE 80 MG | Dormant |
| 01966243 | THEOLAIR SR TAB 200MG | 3M PHARMACEUTICALS, A DIVISION OF 3M CANADA COMPANY | Tablet (Extended-Release) | THEOPHYLLINE 200 MG | Cancelled Post Market |
| 01966251 | THEOLAIR SR TAB 250MG | 3M PHARMACEUTICALS, A DIVISION OF 3M CANADA COMPANY | Tablet (Extended-Release) | THEOPHYLLINE 250 MG | Cancelled Post Market |
| 01966278 | THEOLAIR SR TAB 300MG | 3M PHARMACEUTICALS, A DIVISION OF 3M CANADA COMPANY | Tablet (Extended-Release) | THEOPHYLLINE 300 MG | Cancelled Post Market |
| 01966286 | THEOLAIR SR TAB 500MG | 3M PHARMACEUTICALS, A DIVISION OF 3M CANADA COMPANY | Tablet (Extended-Release) | THEOPHYLLINE 500 MG | Cancelled Post Market |
| 01966235 | THEOLAIR TAB 125MG | 3M PHARMACEUTICALS, A DIVISION OF 3M CANADA COMPANY | Tablet | THEOPHYLLINE 125 MG | Cancelled Post Market |
| 01966227 | THEOLAIR TAB 250MG | 3M PHARMACEUTICALS, A DIVISION OF 3M CANADA COMPANY | Tablet | THEOPHYLLINE 250 MG | Cancelled Post Market |
| 00640093 | THEOPHYLLINE 0.8MG/ML IN 5% DEXTROSE INJ | HOSPIRA HEALTHCARE ULC | Solution | THEOPHYLLINE 0.8 MG; DEXTROSE 5.0 % | Cancelled Post Market |
| 00828726 | THEOPHYLLINE 1.6MG AND 5% DEXTROSE INJ | BAXTER CORPORATION | Solution | THEOPHYLLINE 1.6 MG; DEXTROSE 50 MG | Cancelled Post Market |
| 00828742 | THEOPHYLLINE 4MG AND 5% DEXTROSE INJ | BAXTER CORPORATION | Solution | THEOPHYLLINE 4 MG; DEXTROSE 50 MG | Cancelled Post Market |
| 00261203 | THEOPHYLLINE 80MG/15ML | DESBERGERS LTÉE, DIVISION OF TECHNILAB INC. | Liquid | THEOPHYLLINE 80 MG | Cancelled Post Market |
| 00488070 | THEOPHYLLINE ELIXIR | THERAPEX DIVISION DE E-Z-EM CANADA INC | Elixir | THEOPHYLLINE 80 MG | Cancelled Post Market |
| 00156701 | THEOPHYLLINE ELIXIR | PRO DOC LIMITEE | Elixir | THEOPHYLLINE 80 MG | Cancelled Post Market |
| 00532223 | THEOPHYLLINE ELX | TECHNILAB PHARMA INC. | Elixir | THEOPHYLLINE 80 MG | Cancelled Post Market |
| 00307548 | THEOPHYLLINE ROUGIER ELIXIR | ROUGIER PHARMA DIVISION OF RATIOPHARM INC | Elixir | THEOPHYLLINE 80 MG; ALCOHOL ANHYDROUS 3 ML | Cancelled Post Market |
| 02014181 | UNIPHYL | ELVIUM LIFE SCIENCES | Tablet (Extended-Release) | THEOPHYLLINE 600 MG | Cancelled Post Market |
| 02014165 | UNIPHYL | ELVIUM LIFE SCIENCES | Tablet (Extended-Release) | THEOPHYLLINE 400 MG | Cancelled Post Market |
International API supply for THEOPHYLLINE
3 valid EDQM Certificates of Suitability from 3 holders. 5 active FDA Drug Master Files.
Request a quote for THEOCHRON SRT 300MG